arginine has been researched along with neuropeptide y, leu(31)-pro(34)- in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (33.33) | 18.2507 |
| 2000's | 10 (41.67) | 29.6817 |
| 2010's | 6 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dumont, Y; Quirion, R; St-Pierre, JA | 1 |
| Cox, HM; Holliday, ND | 1 |
| Fournier, A; Iyengar, S; Pheng, LH; Quirion, R; Regoli, D | 1 |
| Grundemar, L | 2 |
| Chen, X; Cox, BF; Han, S; Naes, L; Westfall, T; Yang, CL | 1 |
| Buckingham, R; Widdowson, PS; Williams, G | 1 |
| Gribkoff, VK; Pieschl, RL; van den Pol, AN; Wisialowski, TA; Yocca, FD | 1 |
| Bolwig, TG; Greisen, MH; Madsen, TM; Mikkelsen, JD; Nielsen, SM | 1 |
| Chiba, S; Yang, XP | 2 |
| Bryan, RM; Edvinsson, L; You, J | 1 |
| Malmström, RE | 1 |
| Bell, D; McDermott, BJ; Nicholl, SM; Spiers, Jp | 1 |
| Beck-Sickinger, A; Demuth, H; Dimitrijević, M; Kovacević-Jovanović, V; Stanojević, S; von Hörsten, S; Vujić, V | 1 |
| Chen, SH; Cheung, RT | 1 |
| Deshmukh, M; Lal, B; Mazumdar, M; Sakharkar, AJ; Singru, PS; Subhedar, N | 1 |
| Brownfield, MS; DeJoseph, MR; Dimitrov, EL; Urban, JH | 1 |
| Gourcerol, G; Larauche, M; Million, M; Taché, Y; Wang, L; Wu, SV; Yuan, PQ | 1 |
| Agasse, F; Cadet, JL; Coronas, V; Guégan, C; Jaber, M; Malva, JO; Nicoleau, C; Thiriet, N; Vallette, F | 1 |
| Bastianetto, S; Benoit, CE; Dumont, Y; Flores, G; Fournier, A; Morales-Medina, JC; Quirion, R | 1 |
| Aglawe, MM; Kotagale, NR; Paliwal, NP; Taksande, BG; Umekar, MJ | 1 |
| Bharne, AP; Chopde, CT; Gawande, DY; Kokare, DM; Kotagale, NR; Taksande, BG | 1 |
| Anikina, TA; Krylova, AV; Masliuko, PM; Moiseev, KY; Zefirov, TL; Zverev, AA | 1 |
24 other study(ies) available for arginine and neuropeptide y, leu(31)-pro(34)-
| Article | Year |
|---|---|
Comparative autoradiographic distribution of neuropeptide Y Y1 receptors visualized with the Y1 receptor agonist [125I][Leu31,Pro34]PYY and the non-peptide antagonist [3H]BIBP3226.
Topics: Animals; Arginine; Autoradiography; Iodine Radioisotopes; Male; Neuropeptide Y; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Tritium | 1996 |
The functional investigation of a human adenocarcinoma cell line, stably transfected with the neuropeptide Y Y1 receptor.
Topics: Adrenergic alpha-Agonists; Arginine; Clonidine; HT29 Cells; Humans; Iodine Radioisotopes; Neuropeptide Y; Pancreatic Polypeptide; Peptide Fragments; Peptide YY; Peptides; Receptors, Neuropeptide Y; Somatostatin; Stimulation, Chemical; Transfection; Tumor Cells, Cultured; Vasoactive Intestinal Peptide | 1996 |
The rabbit ileum: a sensitive and selective preparation for the neuropeptide Y Y5 receptor.
Topics: Animals; Appetite Stimulants; Arginine; Binding, Competitive; Diamines; Humans; Ileum; Naphthalenes; Neuropeptide Y; Pancreatic Polypeptide; Peptide YY; Rabbits; Rats; Receptors, Neuropeptide Y; Structure-Activity Relationship | 1997 |
Characterization of the receptor response for the neuropeptide Y-evoked suppression of parasympathetically-mediated contractions in the guinea pig trachea.
Topics: Animals; Arginine; Atropine; Dose-Response Relationship, Drug; Electric Stimulation; Guinea Pigs; In Vitro Techniques; Muscle Contraction; Muscle, Smooth; Neuropeptide Y; Pancreatic Polypeptide; Peptide Fragments; Peptide YY; Receptors, Neuropeptide Y; Trachea | 1997 |
Direct evidence for the role of neuropeptide Y in sympathetic nerve stimulation-induced vasoconstriction.
Topics: Animals; Arginine; Electric Stimulation; Intestines; Male; Muscle, Smooth, Vascular; Neuropeptide Y; Norepinephrine; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Splanchnic Circulation; Sympathetic Nervous System; Vasoconstriction | 1998 |
Distribution of [Leu31,Pro34]NPY-sensitive, BIBP3226-insensitive [125I]PYY(3-36) binding sites in rat brain: possible relationship to Y5 NPY receptors.
Topics: Animals; Arginine; Binding Sites; Binding, Competitive; Brain; Iodine Radioisotopes; Male; Neuropeptide Y; Peptide Fragments; Peptide YY; Rats; Rats, Wistar; Receptors, Neuropeptide Y | 1997 |
Phase shifting of circadian rhythms and depression of neuronal activity in the rat suprachiasmatic nucleus by neuropeptide Y: mediation by different receptor subtypes.
Topics: Action Potentials; Animals; Anti-Anxiety Agents; Arginine; Bicuculline; Circadian Rhythm; Electrophysiology; GABA Antagonists; GABA-A Receptor Antagonists; gamma-Aminobutyric Acid; Male; Neural Inhibition; Neuropeptide Y; Peptide Fragments; Rats; Rats, Inbred Strains; Receptors, Neuropeptide Y; Suprachiasmatic Nucleus | 1998 |
Suppression of sensory C fiber-mediated contractions by neuropeptide Y Y1 receptors in the guinea pig bronchi.
Topics: Animals; Arginine; Bronchi; Bronchoconstriction; Guinea Pigs; Humans; In Vitro Techniques; Nerve Fibers; Neuropeptide Y; Peptide Fragments; Peptide YY; Receptors, Neuropeptide Y | 1998 |
Electroconvulsive stimuli enhance both neuropeptide Y receptor Y1 and Y2 messenger RNA expression and levels of binding in the rat hippocampus.
Topics: Animals; Anti-Anxiety Agents; Arginine; Autoradiography; Down-Regulation; Electric Stimulation Therapy; Epilepsy; Gene Expression; Hippocampus; In Situ Hybridization; Iodine Radioisotopes; Male; Neuropeptide Y; Radioligand Assay; Rats; Rats, Wistar; Receptors, Neuropeptide Y; RNA, Messenger; Seizures | 2000 |
Effects of a selective neuropeptide Y Y(1) receptor antagonist BIBP 3226 on double peaked vasoconstrictor responses to periarterial nerve stimulation in canine splenic arteries.
Topics: Adenosine Triphosphate; Adrenergic alpha-Antagonists; Animals; Anti-Anxiety Agents; Arginine; Dogs; Drug Interactions; Electric Stimulation; Female; In Vitro Techniques; Male; Nerve Tissue; Neuropeptide Y; Norepinephrine; Prazosin; Receptors, Neuropeptide Y; Splenic Artery; Vasoconstriction | 2000 |
Dissociation of potentiation of Leu31 Pro34 neuropeptide Y on adrenergic and purinergic transmission in isolated canine splenic artery.
Topics: Adenosine Triphosphate; Animals; Arginine; Dogs; Electric Stimulation; Female; In Vitro Techniques; Male; Neuropeptide Y; Norepinephrine; Prazosin; Receptors, Adrenergic; Receptors, Neuropeptide Y; Receptors, Purinergic; Splenic Artery; Synaptic Transmission; Vasoconstriction | 2000 |
Neuropeptide Y-mediated constriction and dilation in rat middle cerebral arteries.
Topics: Animals; Arginine; In Vitro Techniques; Male; Middle Cerebral Artery; Muscle, Smooth, Vascular; Neuropeptide Y; Rats; Rats, Long-Evans; Receptors, Neuropeptide Y; Vasoconstriction; Vasodilation | 2001 |
Vascular pharmacology of BIIE0246, the first selective non-peptide neuropeptide Y Y(2) receptor antagonist, in vivo.
Topics: Animals; Arginine; Benzazepines; Blood Flow Velocity; Blood Pressure; Dose-Response Relationship, Drug; Female; Heart Rate; Kidney; Male; Neuropeptide Y; Peptide YY; Receptors, Neuropeptide Y; Spleen; Swine; Vasoconstriction | 2001 |
Neuropeptide Y Y(1) receptor regulates protein turnover and constitutive gene expression in hypertrophying cardiomyocytes.
Topics: Animals; Arginine; Cells, Cultured; Dactinomycin; Dose-Response Relationship, Drug; Gene Expression Regulation; Heart Ventricles; Humans; Male; Myosin Light Chains; Neuropeptide Y; Peptide Fragments; Protein Synthesis Inhibitors; Proteins; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; RNA, Messenger; Time Factors | 2002 |
Effect of neuropeptide Y on inflammatory paw edema in the rat: involvement of peripheral NPY Y1 and Y5 receptors and interaction with dipeptidyl-peptidase IV (CD26).
Topics: Animals; Arginine; Cells, Cultured; Concanavalin A; Dipeptidyl Peptidase 4; Dose-Response Relationship, Drug; Edema; Hydrogen Peroxide; Inflammation; Isoleucine; Macrophages; Male; Neuropeptide Y; Peptide Fragments; Peptide YY; Rats; Rats, Wistar; Receptors, Neuropeptide Y; Thiazoles | 2002 |
Intracerebroventricular injection of a neuropeptide Y-Y1 receptor agonist increases while BIBP3226, a Y1 antagonist, reduces the infarct volume following transient middle cerebral artery occlusion in rats.
Topics: Animals; Anti-Anxiety Agents; Arginine; Infarction, Middle Cerebral Artery; Injections, Intraventricular; Male; Neuropeptide Y; Peptide Fragments; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y | 2003 |
Involvement of neuropeptide Y Y1 receptors in the regulation of LH and GH cells in the pituitary of the catfish, Clarias batrachus: an immunocytochemical study.
Topics: Animals; Anti-Anxiety Agents; Antibody Specificity; Arginine; Catfishes; Female; Growth Hormone; Immunohistochemistry; Luteinizing Hormone; Neuropeptide Y; Neurosecretory Systems; Pituitary Gland; Receptors, Neuropeptide Y; Reproduction | 2006 |
Involvement of neuropeptide Y Y1 receptors in the regulation of neuroendocrine corticotropin-releasing hormone neuronal activity.
Topics: Animals; Anti-Anxiety Agents; Arginine; Biomarkers; Corticotropin-Releasing Hormone; CREB-Binding Protein; Immunohistochemistry; Injections, Intraventricular; Male; Neurons; Neuropeptide Y; Paraventricular Hypothalamic Nucleus; Phosphorylation; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Third Ventricle | 2007 |
Peripheral peptide YY inhibits propulsive colonic motor function through Y2 receptor in conscious mice.
Topics: 5-Hydroxytryptophan; Acute Disease; Animals; Arginine; Benzazepines; Bethanechol; Colon; Consciousness; Diarrhea; Eating; Efferent Pathways; Gastric Emptying; Gastrointestinal Motility; Male; Mice; Mice, Inbred C57BL; Myenteric Plexus; Neuropeptide Y; Parasympathomimetics; Peptide Fragments; Peptide YY; Receptors, Neuropeptide Y; Restraint, Physical; Stress, Physiological | 2010 |
NPY promotes chemokinesis and neurogenesis in the rat subventricular zone.
Topics: Animals; Animals, Newborn; Arginine; Bromodeoxyuridine; Calcium; Cell Differentiation; Cell Movement; Cell Proliferation; Cells, Cultured; Cerebral Ventricles; Enzyme Inhibitors; Nerve Tissue Proteins; Neural Stem Cells; Neurogenesis; Neurons; Neuropeptide Y; Peptide Fragments; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Receptors, Neuropeptide; RNA, Messenger | 2011 |
Role of neuropeptide Y Y₁ and Y₂ receptors on behavioral despair in a rat model of depression with co-morbid anxiety.
Topics: Amygdala; Analysis of Variance; Animals; Anxiety; Arginine; Autoradiography; Benzazepines; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Delivery Systems; Exploratory Behavior; Hippocampus; Interpersonal Relations; Male; Neuropeptide Y; Olfactory Bulb; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Swimming; Time Factors | 2012 |
Possible involvement of neuropeptide Y Y1 receptors in antidepressant like effect of agmatine in rats.
Topics: Agmatine; Animals; Antidepressive Agents; Arginine; Behavior, Animal; Depression; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Injections, Intraventricular; Male; Motor Activity; Neuropeptide Y; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Swimming | 2013 |
Neuropeptide Y in the central nucleus of amygdala regulates the anxiolytic effect of agmatine in rats.
Topics: Agmatine; Animals; Anti-Anxiety Agents; Anxiety; Arginine; Cell Count; Central Amygdaloid Nucleus; Immunohistochemistry; Male; Motor Activity; Neuropeptide Y; Neuropsychological Tests; Nucleus Accumbens; Photomicrography; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Septal Nuclei | 2014 |
NPY
Topics: Animals; Animals, Outbred Strains; Arginine; Cardiotonic Agents; Dose-Response Relationship, Drug; Heart Atria; Heart Ventricles; Isometric Contraction; Myocardial Contraction; Myocardium; Neuropeptide Y; Rats; Receptors, G-Protein-Coupled; Receptors, Neuropeptide; Tissue Culture Techniques | 2017 |